ID   AGAP1_HUMAN             Reviewed;         857 AA.
AC   Q9UPQ3; B2RTX7; Q541S5; Q6P9D7; Q9NV93;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 4.
DT   07-APR-2021, entry version 203.
DE   RecName: Full=Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1;
DE            Short=AGAP-1;
DE   AltName: Full=Centaurin-gamma-2;
DE            Short=Cnt-g2;
DE   AltName: Full=GTP-binding and GTPase-activating protein 1;
DE            Short=GGAP1;
GN   Name=AGAP1; Synonyms=CENTG2, KIAA1099;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT ILE-671, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND FUNCTION.
RC   TISSUE=Heart;
RX   PubMed=12640130; DOI=10.1128/mcb.23.7.2476-2488.2003;
RA   Xia C., Ma W., Stafford L.J., Liu C., Gong L., Martin J.F., Liu M.;
RT   "GGAPs, a new family of bifunctional GTP-binding and GTPase-activating
RT   proteins.";
RL   Mol. Cell. Biol. 23:2476-2488(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT ILE-671.
RA   Hong W.;
RT   "Kiaa1099 as a member (centaurin gamma2) of the centaurin ArfGAP protein
RT   family.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT ILE-671.
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   GLY-148.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 429-857 (ISOFORM 1), AND VARIANT
RP   ILE-671.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   CHARACTERIZATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS
RP   OF CYS-647 AND ARG-652.
RX   PubMed=12388557; DOI=10.1074/jbc.m202969200;
RA   Nie Z., Stanley K.T., Stauffer S., Jacques K.M., Hirsch D.S., Takei J.,
RA   Randazzo P.A.;
RT   "AGAP1, an endosome-associated, phosphoinositide-dependent ADP-ribosylation
RT   factor GTPase-activating protein that affects actin cytoskeleton.";
RL   J. Biol. Chem. 277:48965-48975(2002).
RN   [8]
RP   INTERACTION WITH THE AP-3 COMPLEX.
RX   PubMed=12967569; DOI=10.1016/s1534-5807(03)00234-x;
RA   Nie Z., Boehm M., Boja E.S., Vass W.C., Bonifacino J.S., Fales H.M.,
RA   Randazzo P.A.;
RT   "Specific regulation of the adaptor protein complex AP-3 by the Arf GAP
RT   AGAP1.";
RL   Dev. Cell 5:513-521(2003).
RN   [9]
RP   SUBUNIT, TISSUE SPECIFICITY, PHOSPHORYLATION, AND INTERACTION WITH GUCY1A3
RP   AND GUCY1B3.
RX   PubMed=15381706; DOI=10.1074/jbc.m410565200;
RA   Meurer S., Pioch S., Wagner K., Mueller-Esterl W., Gross S.;
RT   "AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl
RT   cyclase.";
RL   J. Biol. Chem. 279:49346-49354(2004).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=16079295; DOI=10.1242/jcs.02486;
RA   Nie Z., Fei J., Premont R.T., Randazzo P.A.;
RT   "The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein
RT   complexes AP-1 and AP-3.";
RL   J. Cell Sci. 118:3555-3566(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-836, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-521; SER-605 AND THR-836, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-521, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANTS GLY-82; ILE-671; GLY-798 AND THR-854.
RX   PubMed=15892143; DOI=10.1002/ajmg.b.30180;
RA   Wassink T.H., Piven J., Vieland V.J., Jenkins L., Frantz R., Bartlett C.W.,
RA   Goedken R., Childress D., Spence M.A., Smith M., Sheffield V.C.;
RT   "Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism
RT   susceptibility gene.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 136:36-44(2005).
CC   -!- FUNCTION: GTPase-activating protein for ARF1 and, to a lesser extent,
CC       ARF5. Directly and specifically regulates the adapter protein 3 (AP-3)-
CC       dependent trafficking of proteins in the endosomal-lysosomal system.
CC       {ECO:0000269|PubMed:12640130}.
CC   -!- ACTIVITY REGULATION: GAP activity stimulated by phosphatidylinositol
CC       3,4,5-trisphosphate (PIP3) and, to a lesser extent, by
CC       phosphatidylinositol 4,5-bisphosphate (PIP2). Phosphatidic acid
CC       potentiates PIP2 stimulation.
CC   -!- SUBUNIT: Homodimer. Interacts with several subunits of the AP-3 protein
CC       complex: AP3M1, AP3S1 and AP3S2. Interacts with GUCY1A3 and GUCY1B3.
CC       {ECO:0000269|PubMed:12967569, ECO:0000269|PubMed:15381706}.
CC   -!- INTERACTION:
CC       Q9UPQ3; Q9UHP6: RSPH14; NbExp=3; IntAct=EBI-7159788, EBI-748350;
CC       Q9UPQ3; Q76KX8: ZNF534; NbExp=3; IntAct=EBI-7159788, EBI-17208605;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12388557,
CC       ECO:0000269|PubMed:12640130}. Note=Associates with the endocytic
CC       compartment.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UPQ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPQ3-2; Sequence=VSP_011183;
CC       Name=3;
CC         IsoId=Q9UPQ3-3; Sequence=VSP_011181, VSP_011182;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:12388557,
CC       ECO:0000269|PubMed:12640130, ECO:0000269|PubMed:15381706,
CC       ECO:0000269|PubMed:16079295}.
CC   -!- DOMAIN: The PH domain mediates AP-3 binding.
CC   -!- PTM: Phosphorylated on tyrosines. {ECO:0000269|PubMed:15381706}.
CC   -!- SIMILARITY: Belongs to the centaurin gamma-like family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH60814.1; Type=Miscellaneous discrepancy; Note=A 4-nucleotides insertion of unknown origin disrupts the reading frame.; Evidence={ECO:0000305};
CC       Sequence=BAA83051.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA91862.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY033765; AAK56506.1; -; mRNA.
DR   EMBL; AF413078; AAL04172.1; -; mRNA.
DR   EMBL; AB029022; BAA83051.2; ALT_INIT; mRNA.
DR   EMBL; AC012305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC019047; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC064874; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079400; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC060814; AAH60814.1; ALT_SEQ; mRNA.
DR   EMBL; BC140856; AAI40857.1; -; mRNA.
DR   EMBL; AK001722; BAA91862.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2514.1; -. [Q9UPQ3-2]
DR   CCDS; CCDS33408.1; -. [Q9UPQ3-1]
DR   CCDS; CCDS58756.1; -. [Q9UPQ3-3]
DR   RefSeq; NP_001032208.1; NM_001037131.2. [Q9UPQ3-1]
DR   RefSeq; NP_001231817.1; NM_001244888.1. [Q9UPQ3-3]
DR   RefSeq; NP_055729.2; NM_014914.4. [Q9UPQ3-2]
DR   SMR; Q9UPQ3; -.
DR   BioGRID; 125550; 87.
DR   IntAct; Q9UPQ3; 9.
DR   MINT; Q9UPQ3; -.
DR   STRING; 9606.ENSP00000307634; -.
DR   iPTMnet; Q9UPQ3; -.
DR   PhosphoSitePlus; Q9UPQ3; -.
DR   BioMuta; AGAP1; -.
DR   DMDM; 160332373; -.
DR   EPD; Q9UPQ3; -.
DR   jPOST; Q9UPQ3; -.
DR   MassIVE; Q9UPQ3; -.
DR   PaxDb; Q9UPQ3; -.
DR   PeptideAtlas; Q9UPQ3; -.
DR   PRIDE; Q9UPQ3; -.
DR   ProteomicsDB; 85411; -. [Q9UPQ3-1]
DR   ProteomicsDB; 85412; -. [Q9UPQ3-2]
DR   ProteomicsDB; 85413; -. [Q9UPQ3-3]
DR   Antibodypedia; 34463; 144 antibodies.
DR   Ensembl; ENST00000304032; ENSP00000307634; ENSG00000157985. [Q9UPQ3-1]
DR   Ensembl; ENST00000336665; ENSP00000338378; ENSG00000157985. [Q9UPQ3-2]
DR   Ensembl; ENST00000409457; ENSP00000387174; ENSG00000157985. [Q9UPQ3-3]
DR   GeneID; 116987; -.
DR   KEGG; hsa:116987; -.
DR   UCSC; uc002vvs.4; human. [Q9UPQ3-1]
DR   CTD; 116987; -.
DR   DisGeNET; 116987; -.
DR   GeneCards; AGAP1; -.
DR   HGNC; HGNC:16922; AGAP1.
DR   HPA; ENSG00000157985; Low tissue specificity.
DR   MIM; 608651; gene.
DR   neXtProt; NX_Q9UPQ3; -.
DR   OpenTargets; ENSG00000157985; -.
DR   PharmGKB; PA26412; -.
DR   VEuPathDB; HostDB:ENSG00000157985.18; -.
DR   eggNOG; KOG0705; Eukaryota.
DR   GeneTree; ENSGT00940000154793; -.
DR   InParanoid; Q9UPQ3; -.
DR   OMA; QDIPMIL; -.
DR   OrthoDB; 751525at2759; -.
DR   PhylomeDB; Q9UPQ3; -.
DR   TreeFam; TF317762; -.
DR   PathwayCommons; Q9UPQ3; -.
DR   BioGRID-ORCS; 116987; 4 hits in 992 CRISPR screens.
DR   ChiTaRS; AGAP1; human.
DR   GeneWiki; CENTG2; -.
DR   GenomeRNAi; 116987; -.
DR   Pharos; Q9UPQ3; Tbio.
DR   PRO; PR:Q9UPQ3; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9UPQ3; protein.
DR   Bgee; ENSG00000157985; Expressed in cortical plate and 232 other tissues.
DR   ExpressionAtlas; Q9UPQ3; baseline and differential.
DR   Genevisible; Q9UPQ3; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005543; F:phospholipid binding; IDA:FlyBase.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 2.30.29.30; -; 2.
DR   Gene3D; 3.30.40.160; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR037278; ARFGAP/RecO.
DR   InterPro; IPR001164; ArfGAP_dom.
DR   InterPro; IPR038508; ArfGAP_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001806; Small_GTPase.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF01412; ArfGap; 1.
DR   Pfam; PF00071; Ras; 1.
DR   PRINTS; PR00405; REVINTRACTNG.
DR   SMART; SM00248; ANK; 2.
DR   SMART; SM00105; ArfGap; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF57863; SSF57863; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS50115; ARFGAP; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS51419; RAB; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ANK repeat; Cytoplasm; GTP-binding;
KW   GTPase activation; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Protein transport; Reference proteome; Repeat; Transport; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..857
FT                   /note="Arf-GAP with GTPase, ANK repeat and PH domain-
FT                   containing protein 1"
FT                   /id="PRO_0000074218"
FT   DOMAIN          346..588
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          609..729
FT                   /note="Arf-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00288"
FT   REPEAT          768..797
FT                   /note="ANK 1"
FT   REPEAT          801..830
FT                   /note="ANK 2"
FT   NP_BIND         78..85
FT                   /note="GTP"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         122..126
FT                   /note="GTP"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         178..181
FT                   /note="GTP"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         624..647
FT                   /note="C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00288"
FT   REGION          66..276
FT                   /note="Small GTPase-like"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         663
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BXK8"
FT   MOD_RES         836
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         352..405
FT                   /note="MLLKRSGKSLNKEWKKKYVTLCDNGVLTYHPSLHDYMQNVHGKEIDLLRTTV
FT                   KV -> LPFFVLALTASTYLRPAGARARQSSPWPGPRGGQTSPHCAEGPQSAQLSGAMM
FT                   N (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011181"
FT   VAR_SEQ         406..857
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011182"
FT   VAR_SEQ         442..494
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10470851,
FT                   ECO:0000303|PubMed:12640130, ECO:0000303|Ref.2"
FT                   /id="VSP_011183"
FT   VARIANT         82
FT                   /note="S -> G (in an autistic patient)"
FT                   /evidence="ECO:0000269|PubMed:15892143"
FT                   /id="VAR_026446"
FT   VARIANT         148
FT                   /note="D -> G (in dbSNP:rs17855721)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026447"
FT   VARIANT         671
FT                   /note="V -> I (in dbSNP:rs2034648)"
FT                   /evidence="ECO:0000269|PubMed:10470851,
FT                   ECO:0000269|PubMed:12640130, ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15892143, ECO:0000269|Ref.2"
FT                   /id="VAR_026448"
FT   VARIANT         798
FT                   /note="R -> G (in an autistic patient; dbSNP:rs762355360)"
FT                   /evidence="ECO:0000269|PubMed:15892143"
FT                   /id="VAR_026449"
FT   VARIANT         829
FT                   /note="E -> K (in dbSNP:rs15718)"
FT                   /id="VAR_019550"
FT   VARIANT         854
FT                   /note="P -> T (in a family with an autistic patient;
FT                   dbSNP:rs368301945)"
FT                   /evidence="ECO:0000269|PubMed:15892143"
FT                   /id="VAR_026450"
FT   MUTAGEN         647
FT                   /note="C->S: Loss of GAP activity."
FT                   /evidence="ECO:0000269|PubMed:12388557"
FT   MUTAGEN         652
FT                   /note="R->K: Loss of GAP activity. No effect on AP-3-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:12388557"
FT   CONFLICT        288
FT                   /note="T -> I (in Ref. 1; AAK56506, 2; AAL04172 and 3;
FT                   BAA83051)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   857 AA;  94470 MW;  BBFDB8DA0ECD55E8 CRC64;
     MNYQQQLANS AAIRAEIQRF ESVHPNIYSI YELLERVEEP VLQNQIREHV IAIEDAFVNS
     QEWTLSRSVP ELKVGIVGNL ASGKSALVHR YLTGTYVQEE SPEGGRFKKE IVVDGQSYLL
     LIRDEGGPPE AQFAMWVDAV IFVFSLEDEI SFQTVYHYYS RMANYRNTSE IPLVLVGTQD
     AISSANPRVI DDARARKLSN DLKRCTYYET CATYGLNVER VFQDVAQKIV ATRKKQQLSI
     GPCKSLPNSP SHSSVCSAQV SAVHISQTSN GGGSLSDYSS SVPSTPSTSQ KELRIDVPPT
     ANTPTPVRKQ SKRRSNLFTS RKGSDPDKEK KGLESRADSI GSGRAIPIKQ GMLLKRSGKS
     LNKEWKKKYV TLCDNGVLTY HPSLHDYMQN VHGKEIDLLR TTVKVPGKRP PRATSACAPI
     SSPKTNGLSK DMSSLHISPN SGNVTSASGS QMASGISLVS FNSRPDGMHQ RSYSVSSADQ
     WSEATVIANS AISSDTGLGD SVCSSPSISS TTSPKLDPPP SPHANRKKHR RKKSTSNFKA
     DGLSGTAEEQ EENFEFIIVS LTGQTWHFEA TTYEERDAWV QAIESQILAS LQSCESSKNK
     SRLTSQSEAM ALQSIRNMRG NSHCVDCETQ NPNWASLNLG ALMCIECSGI HRNLGTHLSR
     VRSLDLDDWP VELIKVMSSI GNELANSVWE ESSQGRTKPS VDSTREEKER WIRAKYEQKL
     FLAPLPCTEL SLGQHLLRAT ADEDLRTAIL LLAHGSRDEV NETCGEGDGR TALHLACRKG
     NVVLAQLLIW YGVDVTARDA HGNTALAYAR QASSQECIDV LLQYGCPDER FVLMATPNLS
     RRNNNRNNSS GRVPTII
//
